First-generation Alzheimer's disease detection kit for laboratory use (Applicable to Fluorospectrometer)
First-generation AD detection kit for Beta-amyloid (1-42) protein
First-generation AD detection kit for t-tau protein
First-generation AD detection kit for p-tau protein
First-generation AD detection kit for Beta-amyloid (1-40) protein
Bill Gate said " It's hard to overstate how important finding a reliable, affordable, and easy-to-use diagnostic is for stopping Alzheimer's."
Detection of circulating biomarkers is a new trend for disease diagnosis
Our detection assay is highly sensitive and capable of measuring the content of such proteins in saliva or urine. This assay is practically useful as it is a rapid and low-cost alternative for accurate diagnosis of AD. It has a wide dynamic range and only requires a minute amount of sample (a few microliter). The newly developed assay can potentially serve as a point-of-care tool for the diagnosis of AD.
Our innovation kit
Experimental cut-off of circulating AD biomarkers
Smaller than 1.34 pg/mL
Smaller than 1.6 pg/mL
Larger than 344.59 pg/mL
Larger than 147.5 pg/mL
Peace of mind despite lack of treatment options
Simplicity Conventional instrument Results after 1.5 h